by Eric Christianson | Jun 3, 2026 | Respiratory Case Studies
A 54-year-old female with a history of moderate persistent asthma presented to the hospital with worsening shortness of breath, wheezing, and nighttime cough. Over the previous week, she had been using her rescue inhaler six to eight times daily before ultimately...
by Eric Christianson | Apr 19, 2026 | Respiratory Medication and Disease State Clinical Pearls
Beta-blockers have long been approached with caution in patients with asthma due to their potential to provoke bronchospasm and blunt the effects of rescue inhalers. This risk is largely driven by receptor selectivity. In this article, we will break down the best and...
by Eric Christianson | Jan 25, 2026 | Respiratory Case Studies
In this case study, we outline a likely case of propranolol-induced asthma. Mr. J.S. is a 62-year-old male with a past medical history significant for essential tremor, mild persistent asthma, hypertension, and hyperlipidemia. His asthma has been well controlled for...
by Eric Christianson | Nov 13, 2024 | Respiratory Medication and Disease State Clinical Pearls
Two tests are commonly used in asthma assessments to monitor symptom control and airflow and this blog post will discuss their use and how they determine appropriate treatment options. Important tests pharmacists should know include the Asthma Control Test and a Peak...
by Eric Christianson | Jan 21, 2024 | Respiratory Medication and Disease State Clinical Pearls
There are so many inhalers on the market for asthma and COPD. LABA, LAMA, and ICS products are getting so hard to keep track of! Honestly, it gets a little overwhelming at times to remember them all by brand name and what category and classification they fall into. My...
